Risultati finali
The public project website will serve several purposes, including a) being the central go-to-point for consortium members to look up contact information of other partners and to log into the confidential intranet, b) providing a concise overview of the project’s goals, its work packages, and the scientific background to the general public, and c) continuously informing patients and the general public on project-related events, publications, downloads and newsworthy developments. Patient-relevant information will be made available in several common EU languages.
Project brochure (for patients, laymen and scientists) and professional templatesThe project brochure will be a handy flyer or folder that summarises the project’s vision, why it matters, its key objectives, the partner institutions, basic facts (start date, duration, number of countries, funding amount etc.) for transparency, the website URL, and contact information of the scientific coordinator and the project Manager.
VideoA video will be produced for the general public and patients (target audience) explaining the problem of chronic pain and the secondary problems, the lack of adequate treatment for many chronic pain patients, as well as the key goals of the QSPainRelief project in form of animated filmed interviews with the coordinator and WP leaders.
Jointly with one of the relevant patient organisations, the first layman event will take place within the first 6 months, including a Q & A session at a convenient location (most likely connected to an SC Meeting) where partnering clinicians and researchers explain the scope of the project and answer questions of patients and the general public.
Document identifying the selected drugs out of the list of EU approved medications their simulated CNS drug distribution and ontarget functional concentration derived from clinical studies
Pubblicazioni
Autori:
Adrián Ricarte, James A. R. Dalton, Jesús Giraldo
Pubblicato in:
Journal of Chemical Information and Modeling, Numero 61/3, 2021, Pagina/e 1251-1274, ISSN 1549-9596
Editore:
American Chemical Society
DOI:
10.1021/acs.jcim.0c00890
Autori:
Pedro Renault, Jesús Giraldo
Pubblicato in:
International Journal of Molecular Sciences, Numero 22/1, 2021, Pagina/e 187, ISSN 1422-0067
Editore:
Multidisciplinary Digital Publishing Institute (MDPI)
DOI:
10.3390/ijms22010187
Autori:
Oscar Díaz, Pedro Renault, and Jesús Giraldo
Pubblicato in:
ACS Omega, Numero 7, 42, 2022, Pagina/e 37873–37884, ISSN 2470-1343
Editore:
American Chemical Society (ACS) Publications
DOI:
10.1021/acsomega.2c04980
Autori:
Óscar Díaz, Victor Martín, Pedro Renault, David Romero, Antoni Guillamon, Jesús Giraldo
Pubblicato in:
Drug Discovery Today, Numero Volume 28, Numero 2, 2023, ISSN 1359-6446
Editore:
Elsevier BV
DOI:
10.1016/j.drudis.2022.103441
Autori:
Agustín Bruzzese, James A. R. Dalton, Jesús Giraldo
Pubblicato in:
Scientific Reports, Numero 10/1, 2020, ISSN 2045-2322
Editore:
Nature Publishing Group
DOI:
10.1038/s41598-020-77072-4
Autori:
Bertayli M,Hijma H, Bakker W, Groeneveld GJ, Elassaiss-Schaap S
Pubblicato in:
PAGE. Abstracts of the Annual Meeting of the Population Approach Group in Europe., 2022
Editore:
Population Approach Group in Europe
È in corso la ricerca di dati su OpenAIRE...
Si è verificato un errore durante la ricerca dei dati su OpenAIRE
Nessun risultato disponibile